Clinical Trial: The impact of sarcopenia on the intraoperative remifentanil dosage and postoperative hyperalgesia in patients undergoing laparoscopic radical resection of colorectal cancer: A prospective observational study (China)

Posted On: 2026-11-03

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The impact of sarcopenia on the intraoperative remifentanil dosage and postoperative hyperalgesia in patients undergoing laparoscopic radical resection of colorectal cancer: A prospective observational study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135795

Registration Time: 2026/11/02

Type: Observational study

Primary Sponsor: Jiangsu Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349372

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: The impact of sarcopenia on the intraoperative remifentanil dosage and postoperative hyperalgesia in patients undergoing laparoscopic radical resection of colorectal cancer: A prospective observational study (China)